🧑‍🚀 Top Deals You Can’t Miss

1️⃣ NVIDIA + OpenAI – ~$100B partnership to deploy 10GW of NVIDIA systems, cementing AI’s compute backbone.

2️⃣ Ōura – $100M raise at ~$11B valuation, expanding its dominance in health wearables.

3️⃣ Pfizer – $4.9B buyout of Metsera, adding next-gen obesity drugs to its pharma arsenal.

🧠 Dopamine Dealflow

🌳 Series B+ & Growth

• Ōura (Finland) – $100M raise at ~$11B valuation; investors undisclosed; maker of the Oura Ring health wearable.

• AppZen (San Jose, CA) – $180M Growth; investors not disclosed; agentic AI platform for finance teams.

• AusperBio (San Francisco, CA) – $63M Series B2; backers not disclosed; clinical-stage biotech advancing precision therapies.

• Sevaro Health (New York, NY) – $39M Series B; backers undisclosed; teleneurology platform improving stroke care.

🚀 Series A

• Veezoo (Zurich, Switzerland) – $6M Series A; backers not disclosed; agentic analytics for business teams.

• Mondego Bio (Lisbon, Portugal) – Undisclosed Series A; backers not disclosed; developing PTPN2 inhibitors for immunotherapy.

🌱 Seed & Early Rounds

• Titan (Toronto, Canada) – $7M Seed; investors not disclosed; Solana-based meta-dex aggregator.

• Unit 221B (Jersey City, NJ) – $5M Seed; led by J2 Ventures; cybersecurity & threat intelligence platform eWitness.

• Le Walk (New York, NY) – $4.1M Seed; investors not disclosed; immersive guided experiences app.

• TextYess (Milan, Italy) – €2.4M (~$2.6M) Seed; backers not disclosed; AI-powered WhatsApp eCommerce sales.

🤝 Strategic, M&A & Undisclosed

• NVIDIA + OpenAI – Strategic partnership; ~$100B deal to deploy 10GW of NVIDIA systems.

• Pfizer (New York, NY) – $4.9B acquisition of Metsera; adds incretin & amylin obesity therapies to pipeline.

• Biogen (Cambridge, MA) – Acquiring Alcyone Therapeutics (Lowell, MA); ThecaFlex DRx device for intrathecal ASO delivery. Amount undisclosed.

• Ketone-IQ (San Francisco, CA) – Seven-figure strategic equity (exact amt undisclosed); backers include Jake Paul (Antifund), Jon Jones, Steven Bartlett; leading energy shot brand expanding retail presence.

📈 IPOs / Direct Listings / Issuances / Block Trades

• Emirates Global Aluminum (UAE) – Preparing IPO at a potential $10B–$15B valuation.

• Czechoslovak Group (Czech Republic) – $3.5B IPO with added banks to lead.

• Navan (US) – Filed for IPO; last valued at $9.2B in 2022.

• NOBA (Sweden) – $810M raise at $3.5B valuation in Sweden IPO.

• Maynilad Water Services (Philippines) – $800M IPO; IFC & ADB anchoring.

• Techcom Securities (Vietnam) – $410M IPO; brokerage arm of Techcombank.

• Newmont / Orla Mining (Canada) – $439M block trade divestiture on TSX.

• Yesway (US) – Revived IPO plan; targeting $300M raise.

• MapLight Therapeutics (US) – Filed for IPO; last valued at $816M this year.

• Smyk (Poland) – Planning $118M IPO at $587M valuation.

• Caliber (US) – IPO plans; backed by Hellman & Friedman; several hundred million target.

• Rockpoint Gas Storage (Canada) – Filed for IPO; backed by Brookfield.

• BitGo (US) – Filed for IPO; crypto custody firm.

• Andersen Group (US) – Filed for IPO; tax advisory founded by Arthur Andersen alumni.

💸 VC Funds Raised & Raising

• AZ-VC (Phoenix, AZ) – Launched second fund; size undisclosed; focused on innovation outside coastal markets.

Founders: Want to be featured on @tradedvc? → traded.co/submit/vc

📚 Read of the Day

OpenAI + NVIDIA Go Supersized

$100B Compute Pact ⚡

OpenAI and NVIDIA just announced a strategic partnership to deploy 10 gigawatts of NVIDIA systems—a deal valued around $100B. The move supercharges OpenAI’s ability to train frontier models and cements NVIDIA’s dominance as the AI industry’s hardware backbone.

What’s Being Built

This isn’t just chips—it’s AI infrastructure at nation-scale. The systems will support OpenAI’s next wave of foundation models, giving them faster training cycles and more efficient inference at global scale.

Why NVIDIA Wins Big

By locking in OpenAI, NVIDIA makes sure its GPUs remain the default rails for frontier AI. Each new model trained means billions more in GPU demand—and NVIDIA now has direct upside from the most valuable AI company on the planet.

Why It Matters

• 🤖 For OpenAI: Unmatched compute access to stay ahead in the race with Anthropic, xAI, and Google DeepMind.

• 💾 For NVIDIA: Reinforces its chokehold on the AI stack, making rivals AMD and Intel an afterthought.

• 📈 For investors: Proof that hyperscale AI isn’t slowing down—capital needs are expanding into the hundreds of billions.

👉 Read The Whole Story Here

Bonus Read 💊

Pfizer just announced a $4.9B acquisition of Metsera, adding four next-gen obesity and cardiometabolic therapies to its pipeline. The move positions Pfizer to go head-to-head with Eli Lilly and Novo Nordisk in one of pharma’s fastest-growing markets.

📰 News You Don’t Want To Miss

💊 Pfizer bets $4.9B on Metsera to expand obesity and metabolic drug pipeline

🚙 Tesla teases CyberSUV — a smaller, mass-market sibling to the Cybertruck

🤖 NVIDIA plans $500M stake in UK self-driving startup Wayve

🧠 Neuralink to launch brain-speech trial with human patients in October

⚡ Fusion unicorn CFS locks $1B power deal for its future reactor

🛢️ Exxon, Chevron, and Hess double down on Guyana’s Hammerhead oil field